Globally, experts estimate the prevalence of gout to be between 0.1% and 10%, with an incidence of between 0.3 to 6 cases per 1,000 person-years.1 Although the prevalence and incidence of gout vary by region, both are increasing in many developed countries.
The National Health and Nutrition Examination Survey (NHANES) evaluated the U.S. population, asking “Has a doctor ever told you that you had gout?” The survey used the answer to this question to estimate the lifetime prevalence of gout. The NHANES study found a higher age-adjusted prevalence (3.9%) from 2007–2008 than from 1988–1994 (2.9%). This significant increase in age-adjusted prevalence of gout paralleled an observed increase in hyperuricemia. However, the investigators note the NHANES prevalence values are likely an overestimate, because they are based on self-reported data. Thus, experts have called for more specific studies on the prevalence of gout in the U.S., as well as an evaluation of understudied populations that may have been missed by NHANES.2
New research presented at the Annual European Congress of Rheumatology, EULAR 2018, describes a 26.8% increase in U.S. emergency department (ED) visits for people living with gout.3 The increase occurred between 2006 and 2014. The largest increase was seen in the 45–64 years age group (28%). Gurkirpal Singh, MD, lead study investigator and adjunct clinical professor of medicine at Stanford University in Palo Alto, Calif., suggests the undermanaged of the burden of uncontrolled gout may be driving the dramatic increase in U.S. ED visits over the past nine years.
“Often, the treatment of gout focuses on alleviating the symptoms of painful gout flares. However, when escalating symptoms reach the threshold of an ED visit, this [result] suggests that the underlying accumulation of uric acid may not have been adequately addressed,” explains Dr. Singh in a press release.4
For the study, Dr. Singh and colleagues evaluated data from the Nationwide Emergency Department Samples (NEDS). Over the nine-year period, they found 1.7 million people visited EDs with a primary diagnosis of acute gout. Researchers calculated the prevalence of ED visits with a primary diagnosis of gout increased from 56.5/100,000 population in 2006 to 67/100,000 in 2014 (P<0.001). They also found men accounted for 78% of the ED visits in both 2006 and 2014.
The increase in such a common condition will likely have a growing effect on the healthcare and public health systems. Dr. Singh and colleagues call for improved recognition of the burden of gout in the hope such recognition will translate into earlier diagnosis and more active management. Improved long-term management of gout may help minimize the effect of gout on the healthcare system.
Lara C. Pullen, PhD, is a medical writer based in the Chicago area.
- Kuo CF, Grainge MJ, Zhang W, et al. Global epidemiology of gout: Prevalence, incidence and risk factors. Nat Rev Rheumatol. 2015 Nov;11(11):649–662. Epub 2015 Jul 7.
- Helmick CG, Felson DT, Lawrence RC, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States, part I. Arthritis Rheum. 2008 Jan;58(1):15–25.
- Mithal A, Singh G. Emergency department visits for gout: A dramatic increase in the past decade (OP0185). Ann Rheum Dis. 2018 Jun;77:141–142.
- Horizon Pharma Plc. Epidemiologic study findings show 27% increase in emergency department visits for gout in the U.S. over the past decade. 2018 Jun 14.